Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Danling Gu"'
Autor:
Handong Sun, Lishen Zhang, Zhonglin Wang, Danling Gu, Mengyan Zhu, Yun Cai, Lu Li, Jiaqi Tang, Bin Huang, Bakwatanisa Bosco, Ning Li, Lingxiang Wu, Wei Wu, Liangyu Li, Yuan Liang, Lin Luo, Quanzhong Liu, Yanhui Zhu, Jie Sun, Liang Shi, Tiansong Xia, Chuang Yang, Qitong Xu, Xue Han, Weiming Zhang, Jianxia Liu, Dong Meng, Hua Shao, Xiangxin Zheng, Shuqin Li, Hua Pan, Jing Ke, Wenying Jiang, Xiaolan Zhang, Xuedong Han, Jian Chu, Hongyin An, Juyan Ge, Chi Pan, Xiuxing Wang, Kening Li, Qianghu Wang, Qiang Ding
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-18 (2023)
Abstract Male breast cancer (MBC) is a rare but aggressive malignancy with cellular and immunological characteristics that remain unclear. Here, we perform transcriptomic analysis for 111,038 single cells from tumor tissues of six MBC and thirteen fe
Externí odkaz:
https://doaj.org/article/5172e6365bec43b8ad025eb78767e303
CircRIC8B regulates the lipid metabolism of chronic lymphocytic leukemia through miR199b-5p/LPL axis
Autor:
Zijuan Wu, Danling Gu, Ruixin Wang, Xiaoling Zuo, Huayuan Zhu, Luqiao Wang, Xueying Lu, Yi Xia, Shuchao Qin, Wei Zhang, Wei Xu, Lei Fan, Jianyong Li, Hui Jin
Publikováno v:
Experimental Hematology & Oncology, Vol 11, Iss 1, Pp 1-15 (2022)
Abstract Objective Circular RNAs (circRNAs) play a critical role in the modulation of tumor metabolism. However, the expression patterns and metabolic function of circRNAs in chronic lymphocytic leukemia (CLL) remain largely unknown. This study aimed
Externí odkaz:
https://doaj.org/article/104da160c18045f5b51e98322bfec4b4
Autor:
Zijuan Wu, Luqiao Wang, Lei Fan, Hanning Tang, Xiaoling Zuo, Danling Gu, Xueying Lu, Yue Li, Jiazhu Wu, Shuchao Qin, Yi Xia, Huayuan Zhu, Li Wang, Wei Xu, Jianyong Li, Hui Jin
Publikováno v:
Molecular Oncology, Vol 16, Iss 16, Pp 2920-2935 (2022)
Ibrutinib exerts promising anticancer effects in chronic lymphocytic leukaemia (CLL). However, acquired resistance occurs during treatment, necessitating the exploration of underlying mechanisms. Although three‐dimensional genome organization has b
Externí odkaz:
https://doaj.org/article/9c293ac4caa34f1b972808bacc774fbd
Autor:
David Rosen, Laurence Fayadat-Dilman, Yiwei Zhang, Konstantin Dobrenkov, Elliot Chartash, Richard Wnek, Smita Mauze, Hans van Eenennaam, Judith Stammen-Vogelzangs, Ying Yu, Marco Guadagnoli, Lars Guelen, Thierry O Fischmann, Jerelyn Wong, Nikolina Bąbała, Jozef Wagenaars, Veronica Juan, Winnie Prosise, Maurice Habraken, Imke Lodewijks, Danling Gu, Jeanne Baker, David Lutje Hulsik, Lilian Driessen-Engels, Dan Malashock, Joost Kreijtz, Astrid Bertens, Evert de Vries, Astrid Bovens, Arne Bramer, Sean Troth, Svetlana Sadekova, Andrea van Elsas, Jason K Cheung, Jannie Borst, Amy M Beebe
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 9 (2022)
Background Immune checkpoint inhibitors (ICI) have radically changed cancer therapy, but most patients with cancer are unresponsive or relapse after treatment. MK-5890 is a CD27 agonist antibody intended to complement ICI therapy. CD27 is a member of
Externí odkaz:
https://doaj.org/article/cc59fd0a12e04837b4168ce751ae8a2b
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-15 (2021)
Abstract B cell receptor (BCR) signaling is involved in the pathogenesis of B cell malignancies. Activation of BCR signaling promotes the survival and proliferation of malignant B cells. Bruton tyrosine kinase (BTK) is a key component of BCR signalin
Externí odkaz:
https://doaj.org/article/557fae3ccc224792b23426e77330dc47
Autor:
Luqiao Wang, Zijuan Wu, Yi Xia, Xueying Lu, Ji Li, Lei Fan, Chun Qiao, Hairong Qiu, Danling Gu, Wei Xu, Jianyong Li, Hui Jin
Publikováno v:
Clinical and Translational Medicine, Vol 12, Iss 5, Pp n/a-n/a (2022)
Abstract Background Diffuse large B‐cell lymphoma (DLBCL) is the most common subtype of non‐Hodgkin lymphoma. Histone deacetylase inhibitors (HDACis) have been widely applied in multiple tumours, but the expected efficacy was not observed in DLBC
Externí odkaz:
https://doaj.org/article/6e11263b717f446288de34e24f57fbf5
Autor:
Daqi Li, Qian Zhang, Lu Li, Kexin Chen, Junlei Yang, Deobrat Dixit, Ryan C. Gimple, Shusheng Ci, Chenfei Lu, Lang Hu, Jiancheng Gao, Danyang Shan, Yangqing Li, Junxia Zhang, Zhumei Shi, Danling Gu, Wei Yuan, Qiulian Wu, Kailin Yang, Linjie Zhao, Zhixin Qiu, Deguang Lv, Wei Gao, Hui Yang, Fan Lin, Qianghu Wang, Jianghong Man, Chaojun Li, Weiwei Tao, Sameer Agnihotri, Xu Qian, Yu Shi, Yongping You, Nu Zhang, Jeremy N. Rich, Xiuxing Wang
Publikováno v:
Cancer Research. 82:3321-3334
Glioblastoma (GBM) is a complex ecosystem that includes a heterogeneous tumor population and the tumor-immune microenvironment (TIME), prominently containing tumor-associated macrophages (TAM) and microglia. Here, we demonstrated that β2-microglobul
Autor:
David Parry, Ming Liu, Suining Lee, Yunsheng Hsieh, Danling Gu, Wei Wang, Bhagyashree Bhagwat, Ervin Penaflor, Wolfgang Seghezzi, Derek Wiswell, Lorena Taricani, Nicole Davis, Frances Shanahan, Marc Labroli, Michael P. Dwyer, Kamil Paruch, Timothy J. Guzi
Supplementary Table 7 from Targeting the Replication Checkpoint Using SCH 900776, a Potent and Functionally Selective CHK1 Inhibitor Identified via High Content Screening
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08467be88e5ae6f26a63e170eb49e9e8
https://doi.org/10.1158/1535-7163.22502688.v1
https://doi.org/10.1158/1535-7163.22502688.v1
Autor:
David Parry, Ming Liu, Suining Lee, Yunsheng Hsieh, Danling Gu, Wei Wang, Bhagyashree Bhagwat, Ervin Penaflor, Wolfgang Seghezzi, Derek Wiswell, Lorena Taricani, Nicole Davis, Frances Shanahan, Marc Labroli, Michael P. Dwyer, Kamil Paruch, Timothy J. Guzi
Supplementary Figure 1 from Targeting the Replication Checkpoint Using SCH 900776, a Potent and Functionally Selective CHK1 Inhibitor Identified via High Content Screening
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c5bd4321320341097db170c455b546c
https://doi.org/10.1158/1535-7163.22502796
https://doi.org/10.1158/1535-7163.22502796
Autor:
David Parry, Ming Liu, Suining Lee, Yunsheng Hsieh, Danling Gu, Wei Wang, Bhagyashree Bhagwat, Ervin Penaflor, Wolfgang Seghezzi, Derek Wiswell, Lorena Taricani, Nicole Davis, Frances Shanahan, Marc Labroli, Michael P. Dwyer, Kamil Paruch, Timothy J. Guzi
Supplementary Table 4 from Targeting the Replication Checkpoint Using SCH 900776, a Potent and Functionally Selective CHK1 Inhibitor Identified via High Content Screening
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::148621f57e4e535a39b5f2b12408413d
https://doi.org/10.1158/1535-7163.22502715.v1
https://doi.org/10.1158/1535-7163.22502715.v1